AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Imagion Biosystems

0.023

-0.003-11.54%

Volume:4.47M

Turnover:109.19K

Market Cap:11.28M

PE:-1.35

High:0.026

Open:0.025

Low:0.023

Close:0.026

52wk High:0.055

52wk Low:0.011

Shares:490.59M

Float Shares:172.45M

Volume Ratio:1.75

T/O Rate:2.59%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.017

EPS(LYR):-0.046

ROE:-2804.87%

ROA:-83.89%

PB:-2.92

PE(LYR):-0.50

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Imagion Biosystems Submits IND Application to FDA for MagSense HER2 Imaging Agent

Medical-Imaging Company Imagion Biosystems Lodges Ind With FDA for Phase 2 Trial of Magsense® Her2 Targeted Imaging Agent

THOMSON REUTERS

Imagion Biosystems Ltd - Enrollment for Phase 2 Trial Could Begin Q1 2026

THOMSON REUTERS

Imagion Biosystems Ltd-Appendix 4C and Quarterly Activities Report - September 2025

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IBX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","market":"AU","secType":"STK","nameCN":"Imagion Biosystems","latestPrice":0.023,"timestamp":1770354720000,"preClose":0.026,"halted":0,"volume":4474935,"delay":0,"changeRate":-0.11538461538461536,"nameEN":"Imagion Biosystems","floatShares":172453894,"shares":490590239,"eps":-0.017095,"marketStatus":"Market Closed","change":-0.003,"latestTime":"02-06 16:12:00 AEDT","open":0.025,"high":0.026,"low":0.023,"amount":109189,"amplitude":0.115385,"askPrice":0.025,"askSize":400000,"bidPrice":0.023,"bidSize":1757744,"shortable":3,"etf":0,"ttmEps":-0.017095,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770591600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.026,"openAndCloseTimeList":[[1770332400000,1770354000000]],"volumeRatio":1.7485173530773814,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","floatShares":172453894,"roa":"-83.89%","roe":"-2804.87%","lyrEps":-0.045985,"volumeRatio":1.7485173530773814,"shares":490590239,"dividePrice":0,"high":0.026,"amplitude":0.115385,"preClose":0.026,"low":0.023,"week52Low":0.011,"pbRate":"-2.92","psRate":"10.69","week52High":0.055,"institutionHeld":0,"latestPrice":0.023,"committee":0.629242,"eps":-0.017095,"divideRate":0,"volume":4474935,"delay":0,"ttmEps":-0.017095,"open":0.025,"prevYearClose":0.025,"prevWeekClose":0.024,"prevMonthClose":0.024,"prevQuarterClose":0.025,"fiveDayClose":0.024,"twentyDayClose":0.03,"sixtyDayClose":0.021,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-11-16","symbol":"IBX.AU","defaultRemindTime":1700089200000,"type":"split","dateTimestamp":1700053200000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608580538","title":"Imagion Biosystems Submits IND Application to FDA for MagSense HER2 Imaging Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2608580538","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608580538?lang=en_us&edition=fundamental","pubTime":"2026-02-04 00:30","pubTimestamp":1770136218,"startTime":"0","endTime":"0","summary":"Imagion Biosystems Ltd. has submitted an Investigational New Drug  application to the U.S. Food and Drug Administration  for its MagSense HER2 targeted imaging agent. The company plans to initiate a Phase 2 clinical trial to evaluate the imaging agent for detecting nodal metastases in HER2-positive breast cancer patients, pending FDA approval. Enrollment for the trial could begin as early as the first quarter of 2026, based on historical FDA review timelines. Imagion Biosystems has engaged all necessary strategic trial partners and is advancing logistical preparations in compliance with Good Clinical Practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imagion Biosystems Ltd. published the original content used to generate this ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL3fhmTg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBX.AU","BK7007"],"gpt_icon":0},{"id":"2608805855","title":"Medical-Imaging Company Imagion Biosystems Lodges Ind With FDA for Phase 2 Trial of Magsense® Her2 Targeted Imaging Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2608805855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608805855?lang=en_us&edition=fundamental","pubTime":"2026-02-04 00:30","pubTimestamp":1770136200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUA84DDZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IBX.AU"],"gpt_icon":0},{"id":"2608058008","title":"Imagion Biosystems Ltd - Enrollment for Phase 2 Trial Could Begin Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2608058008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608058008?lang=en_us&edition=fundamental","pubTime":"2026-02-04 00:30","pubTimestamp":1770136200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUA84DDZD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IBX.AU"],"gpt_icon":0},{"id":"2577891057","title":"Imagion Biosystems Ltd-Appendix 4C and Quarterly Activities Report - September 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2577891057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577891057?lang=en_us&edition=fundamental","pubTime":"2025-10-21 06:42","pubTimestamp":1761000173,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nTUE7SCWW1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBX.AU","BK7007"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}